Φορτώνει......
How close are we to therapies for Sanfilippo disease?
Sanfilippo disease is one of mucopolysaccharidoses (MPS), a group of lysosomal storage diseases characterized by accumulation of partially degraded glycosaminoglycans (GAGs). It is classified as MPS type III, though it is caused by four different genetic defects, determining subtypes A, B, C and D....
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Metab Brain Dis |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer US
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5769821/ https://ncbi.nlm.nih.gov/pubmed/28921412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11011-017-0111-4 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|